This article is more than 5 years old. Information may no longer be current.

Revenues, sales increase for Bausch & Lomb

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

ROCHESTER, N.Y. — Bausch & Lomb reported sales of $566.5 million during the second quarter of 2004, an increase of 11% from sales in the second quarter of 2003. Each of the company’s product categories reported solid sales growth, according to a press release from B&L.

Second quarter U.S. revenues were $225.6 million, an increase of 10% from the same period 1 year ago. The United States comprises 40% of B&L’s overall earnings, the company said in its press release. The Americas region reported a 9% increase in sales; Europe, Middle East and Africa reported a 9% increase, and Asia reported an 18% increase.

By product category, refractive surgical products posted the largest gain from the previous year (17%), followed by contact lenses (12%), pharmaceuticals (11%), cataract and vitreoretinal (9%) and lens care (7%), the company said.

Overall, however, contact lenses are the largest-selling of B&L’s product lines, generating $167.1 million in sales during the quarter. Sales of pharmaceuticals totaled $139.4 million, followed by lens care at $134.9 million, cataract and vitreoretinal at $89.5 million and refractive products at $35.6 million.

The revenue growth in refractive surgical products was primarily driven by higher sales of per-procedure cards, microkeratome blades and upgrades to the Zyoptix platform for customized LASIK surgery, the company said.